Disease Susceptibility: Clinical Trials

4 trials for Disease Susceptibility, newest first

ClinicalTrials Daily  ·  Areas  ·  Conditions  ·  Drugs  ·  Sponsors  ·  

2 recruiting, 1 active not recruiting, 1 completed. 4 Phase 4.

By phase and status

PhaseTrialsStatus
Phase 44Recruiting 2, Active not recruiting 1, Completed 1

Follow Disease Susceptibility: new trials by email Literature Review of Disease Susceptibility trials Research Report on Disease Susceptibility

Trials (filtered) newest first · largest first

All 4 trials

Tick up to 5 trials to compare them side by side (eligibility, arms, endpoints, adverse events) in a Literature Matrix.

TrialPhaseStatusSponsorEnrollmentStartUpdated
Mechanistic Clinical Trial Comparing the Pharmacokinetics/Pharmacodynamics of Metoprolol in Heart Failure With Reduced Ejection Fraction Patients With Low vs. High Polygenic Score
Metoprolol Succinate, Beta-Blocker Polygenic Score, Illumina Infinium Global Diversity Array with Enhanced Pharmacogenomics (PGx) - Heart Failure With Reduced Ejection Fraction
Phase 4RecruitingUniversity of Michigan1002026-12-012026-10-15
Polygenic Risk Driven Pragmatic Statin Trial for Heart Disease Prevention
Rosuvastatin 20mg - PRS-based Primary Prevention of CVD
Phase 4Active not recruitingMikk JÜRISSON27142025-03-262026-05-13
GLUCOSE-MGH: Genetic Links Understood Through Challenge With Oral Semaglutide Exposure at MGH
oral semaglutide, Mixed Meal Tolerance Test (MMTT) - Genetic Predisposition, Metabolic Diseases
Phase 4RecruitingMassachusetts General Hospital1252024-03-122026-07-08
Efficacy of the Use of Genetic Markers in the Choice of the Pharmacological Treatment of Smoking (GENTSMOKING)
Varenicline Tartrate or bupropion - Smoking Cessation, Genetic Predisposition
Phase 4CompletedUniversity of Sao Paulo General Hospital3612016-11-012022-12-21

Narrower conditions

Genetic Predisposition to Disease (2)  ·  Genetic Risk Score (2)  ·  Diabetes Mellitus, Type 2 (1)  ·  Metabolic Diseases (1)  ·  Smoking Cessation (1)

Broader conditions

Disease Attributes (4)  ·  Pathologic Processes (4)  ·  Pathological Conditions, Signs and Symptoms (4)  ·  Genetic Predisposition to Disease (2)  ·  Behavior (1)  ·  Diabetes Mellitus (1)  ·  Endocrine System Diseases (1)  ·  Glucose Metabolism Disorders (1)  ·  Health Behavior (1)  ·  Nutritional and Metabolic Diseases (1)

Interventions

Bupropion (1)  ·  Metoprolol (1)  ·  Rosuvastatin Calcium (1)  ·  Varenicline (1)  ·  semaglutide (1)

Sponsors

Massachusetts General Hospital (1)  ·  Mikk JÜRISSON (1)  ·  University of Michigan (1)  ·  University of Sao Paulo General Hospital (1)

Countries

United States (2)  ·  Brazil (1)  ·  Estonia (1)

Top investigators

Jaqueline R Scholz, MD.Phd (1)  ·  Jasmine Luzum, PharmD, PhD (1)  ·  Josephine Li, MD (1)  ·  Margus Viigimaa, PhD (1)

Results publications

PMID 38628555, PMID 38756738, PMID 42203295

NIH funding

K23DK131345 (1), R01HL178410 (1)